In this context, upregulation of the lncRNA nuclear-enriched autosomal transcript 1 (NEAT1) in PBMCs of HCC patients reduces CD8+ T cell survival and cytotoxicity, through modifications in the miR-155/Tim-3 axis. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.